|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/33 | |
| A61K 47/10 | |||
| A61K 47/32 | |||
| A61P 11/00 |
| (11) | Patento numeris | 2021797 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07762162.1 |
| Europos patento paraiškos padavimo data | 2007-05-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-02-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-11-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/068857 |
| Data | 2007-05-14 |
| (87) | Numeris | WO 2007/134279 |
| Data | 2007-11-22 |
| (30) | Numeris | Data | Šalis |
| 799795 P | 2006-05-12 | US |
| (72) |
YOUNG, Christopher, R., US
ROWE, Charles, William, US
|
| (73) |
Vertex Pharmaceuticals, Inc.,
130 Waverly Street, Cambridge, MA 02139,
US
|
| (54) | COMPOSITIONS OF N-Ý2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL¨-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |
| COMPOSITIONS OF N-Ý2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL¨-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |